Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes. #lymphoma #lymsm https://t.co/Lm9pp6smMe
2,454 followers
925 followers
New article: Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes. https://t.co/xXaN2uOSFF #DLBCL #lymsm #hematology
3,012 followers
New Research: Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes: Post-transplant lymphoproliferative… https://t.co/URtPWvUzZa #medicalcare